APA

Chan I. H., Jain R., Tessmer M. S., Gorman D., Mangadu R., Sathe M., Vives F., Moon C., Penaflor E., Turner S., Ayanoglu G., Chang C., Basham B., Mumm J. B., Pierce R. H., Yearley J. H., McClanahan T. K., Phillips J. H., Cua D. J., Bowman E. P., Kastelein R. A. & LaFace D. (20150130). Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. : Mucosal immunology.

Chicago

Chan I H, Jain R, Tessmer M S, Gorman D, Mangadu R, Sathe M, Vives F, Moon C, Penaflor E, Turner S, Ayanoglu G, Chang C, Basham B, Mumm J B, Pierce R H, Yearley J H, McClanahan T K, Phillips J H, Cua D J, Bowman E P, Kastelein R A and LaFace D. 20150130. Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. : Mucosal immunology.

Harvard

Chan I. H., Jain R., Tessmer M. S., Gorman D., Mangadu R., Sathe M., Vives F., Moon C., Penaflor E., Turner S., Ayanoglu G., Chang C., Basham B., Mumm J. B., Pierce R. H., Yearley J. H., McClanahan T. K., Phillips J. H., Cua D. J., Bowman E. P., Kastelein R. A. and LaFace D. (20150130). Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. : Mucosal immunology.

MLA

Chan I H, Jain R, Tessmer M S, Gorman D, Mangadu R, Sathe M, Vives F, Moon C, Penaflor E, Turner S, Ayanoglu G, Chang C, Basham B, Mumm J B, Pierce R H, Yearley J H, McClanahan T K, Phillips J H, Cua D J, Bowman E P, Kastelein R A and LaFace D. Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. : Mucosal immunology. 20150130.